About

David Barrie Richardson, PhD, is a Professor of Environmental and Occupational Health at the University of California, Irvine, and serves as Associate Dean for Research at the Joe C. Wen School of Population & Public Health. He earned his Ph.D. and M.S.P.H. in epidemiology from the University of North Carolina at Chapel Hill and holds a B.A. in Political Science from Duke University. Dr. Richardson's research primarily focuses on the health effects of occupational and environmental exposures, with a particular emphasis on carcinogens. His work includes studies of cancer among nuclear workers at various U.S. Department of Energy facilities and investigations of cancer among the survivors of the atomic bombings in Hiroshima and Nagasaki. He has contributed significantly to understanding the risks associated with low-dose ionizing radiation and occupational exposures in nuclear power and other settings.

Research topics

• Computer Science
• Psychology
• Mathematics education
• Computer Security
• Pedagogy
• Business
• Programming language
• Internet privacy
• World Wide Web
• Medicine
• Medical education
• Mathematics
• Risk analysis (engineering)

Selected publications

• RINATABART SESUTECAN MONOTHERAPY IN PATIENTS WITH ADVANCED ENDOMETRIAL CANCER: PART F OF THE PHASE 1/2 RAINFOL™-01 STUDY

  International Journal of Gynecological Cancer · 2025-11-01

  article1st authorCorresponding
  PublisherDOI

• REJOICE-OVARIAN02: A PHASE 1B/2 STUDY OF RALUDOTATUG DERUXTECAN WITH OTHER ANTICANCER AGENTS IN PARTICIPANTS WITH RELAPSED OVARIAN CANCER AFTER PLATINUM-BASED CHEMOTHERAPY

  International Journal of Gynecological Cancer · 2025-11-01

  articleOpen access
  PublisherOA PDFDOI

• Phase IB study of the BMI-1 inhibitor PTC596 (unesbulin) plus neoadjuvant paclitaxel-carboplatin in advanced ovarian cancer

  Gynecologic Oncology · 2025-09-01

  article1st authorCorresponding
  PublisherDOI

• PART C OF RAINFOL™-01: A PHASE 1/2 STUDY OF SINGLE-AGENT RINATABART SESUTECAN IN PATIENTS WITH ADVANCED AND/OR METASTATIC PLATINUM-RESISTANT OVARIAN CANCER

  International Journal of Gynecological Cancer · 2025-11-01

  article
  PublisherDOI

• A phase I, first-in-human, dose escalation and expansion study to evaluate the safety and tolerability of XmAb541 (Claudin 6 x CD3) T-cell engaging bispecific antibody in advanced solid tumors

  Gynecologic Oncology · 2025-09-01

  article
  PublisherDOI

• Part C of a phase I/II study evaluating single agent rinatabart sesutecan in patients with advanced and/or metastatic platinum-resistant ovarian cancer

  Gynecologic Oncology · 2025-09-01

  article
  PublisherDOI

• Sequencing of mirvetuximab soravtansine and weekly paclitaxel: Does order matter?

  Gynecologic Oncology · 2025-09-01

  article
  PublisherDOI

• UPLIFT (ENGOT-OV67/GOG-3048): Results from the phase II trial of upifitamab rilsodotin (UpRi; XMT-1536), a NaPi2b-directed dolaflexin antibody-drug conjugate in platinum-resistant ovarian cancer

  Gynecologic Oncology · 2024-10-09 · 4 citations

  article1st authorCorresponding
  PublisherDOI

• Treatment monitoring utilizing ctDNA-based molecular residual disease detection in early-stage endometrial cancer

  Gynecologic Oncology · 2024-10-09

  article
  PublisherDOI

• UPLIFT (ENGOT-ov67/GOG-3048): Results from the phase II trial of upifitamab rilsodotin, a NaPi2b-directed dolaflexin antibody-drug conjugate, in platinum-resistant ovarian cancer

  Gynecologic Oncology · 2024-10-09 · 2 citations

  article1st authorCorresponding
  PublisherDOI

Recent grants

• CS10K:CS1C@OC-Building a Local Area Network of Computer Science Teachers

  NSF · $1.0M · 2016–2021

• CONECTAR: Collaborative Network of Educators for Computational Thinking for All Research

  NSF · $316k · 2017–2020

Frequent coauthors

• Hadar Ziv

  University of California, Irvine

  32 shared

• Birgit Penzenstadler

  Active Technologies (Italy)

  23 shared

• Ankita Raturi

  Purdue University West Lafayette

  17 shared

• Lori A. Clarke

  University of Massachusetts Amherst

  17 shared

• André van der Hoek

  University of California, Irvine

  16 shared

• Bill Tomlinson

  University of California, Irvine

  16 shared

• Marcio S. Dias

  Durham University

  14 shared

• Kathleen N. Moore

  University of Oklahoma Health Sciences Center

  12 shared

Labs

• Joe C. Wen School of Population & Public HealthPI

Education

• Ph.D., Public Health

  University of California, Los Angeles

  2000

• Other, Public Health

  University of California, Los Angeles

  1996

• B.A., International Development Studies

  University of California, Los Angeles

  1993

Awards & honors

• Leading occupational health researcher awarded nearly $600,0…
• National committee concludes study on Manhattan Project Vete…
• A comprehensive guide to addressing bias in epidemiological…
• New study provides crucial insights into radiation exposure’…
• Environmental health expert David Richardson to serve on a n…